Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)-Reference-Cited by-同舟云学术

Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

Published:2012-06-19 Issue:3 Volume:110 Page:328-335
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Sartor A. Oliver,Fitzpatrick John M.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10818.x/fullpdf

Reference46 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

3. American Cancer Society. Key statistics about prostate cancer 2011 http://www.cancer.org/Cancer/ProstateCancer/DetailedGuide/prostate-cancer-key-statistics

4. [Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer];Gillitzer;Urologe A,2009

5. Physician visits prior to treatment for clinically localized prostate cancer;Jang;Arch Intern Med,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer;Journal of Urology;2023-06

2. Establishment of an age‐ and tumor microenvironment‐related gene signature for survival prediction in prostate cancer;Cancer Medicine;2022-05-09

3. The Growth of Integrated Care Models in Urology;Urologic Clinics of North America;2021-05

4. EDITORIAL COMMENT;Urology;2021-02

5. Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies;Urology;2021-02